Bromuconazole

CAS: 116255-48-2

Ref. 3D-REA25548

Product Information

• Name: Bromuconazole
• Synonyms: 1-((2RS,4RS,2RS,4SR)-4-Bromo-2-(2,4-dichlorophenyl) tetrahydrofurfuryl)-1H-1,2,4-triazole, 1-((2Rs,4Rs,2Rs,4Sr)-4-Bromo-2-(2,4-Dichlorophenyl)Tetrahydrofurfuryl)-1H-1,, 1-((4-Bromo-2-(2,4-Dichlorophenyl)Tetrahydro-2-Furanyl)Methyl)-1H-1,2,4-Tria, 1H-1,2,4-Triazole, 1-[[4-bromo-2-(2,4-dichlorophenyl)tetrahydro-2-furanyl]methyl]-, 1H-1,2,4-Triazole,1-((4-Bromo-2-(2,4-Dichlorophenyl)Tetrahydro-2-Furanyl)Methy, 2,5-Anhydro-4-bromo-1,3,4-trideoxy-2-C-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)pentitol, 2,5-anhydro-4-bromo-1,3,4-trideoxy-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)pentitol, Bromoconazole, Bromuconazol, Granit, Granit (pesticide), Ls 860263, Pentitol, 2,5-anhydro-4-bromo-1,3,4-trideoxy-2-C-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)-, Vectra
• CAS: 116255-48-2

Description

Bromuconazole is a medicinal compound that has been shown to inhibit the cell cycle and promote apoptosis in cancer cells. This inhibitor targets protein kinases, which are enzymes that play a critical role in regulating cell growth and division. Bromuconazole has been found to be particularly effective against Chinese hamster ovary (CHO) cells, as well as human cancer cell lines. It inhibits the activity of xylose kinases, which are involved in the metabolism of carbohydrates, leading to decreased energy production and ultimately cell death. In addition, bromuconazole has been shown to have potent anti-tumor effects in vivo, reducing tumor size and increasing survival rates in animal models. This compound can be detected in urine samples following administration, making it a useful tool for research into the mechanisms of cancer development and treatment.

• Brand: Biosynth

Chemical properties

• Molecular weight: 377.1 g/mol
• Formula: C₁₃H₁₂BrCl₂N₃O
• Purity: Min. 95%